Q&A: Lonza CGT president Daniel Palmacci talks manufacturing amid lower sales outlook
In the past few weeks, Lonza has announced several new facility builds, from its partnership with Vertex Pharmaceuticals on a new cell and gene therapy (CGT) building in Portsmouth, NH, to the expansion of its small-scale mRNA facility in Geleen, the Netherlands. These moves expand Lonza’s manufacturing territory with existing CGT facilities in Boston, as well as in Siena, Italy and in Singapore.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.